CRBP Earnings Corbus Pharmaceuticals Holdings, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -1.23 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -5.90 | 2026-03-09 | 10-K |
| Q3 2025 | 2025-09-30 | -4.73 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -2.83 | 2025-08-05 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.39 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -3.68 | 2026-03-09 | 10-K |
| Q3 2025 | 2024-09-30 | -2.92 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.75 | 2025-08-05 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.83 | 2025-05-06 | 10-Q |
| FY 2024 | 2023-12-31 | -10.31 | 2025-03-11 | 10-K |
| Q3 2024 | 2023-09-30 | -8.52 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -6.27 | 2024-08-06 | 10-Q |
| Q1 2024 | 2023-03-31 | -4.24 | 2024-05-07 | 10-Q |
| FY 2023 | 2022-12-31 | -10.15 | 2024-03-12 | 10-K |
| Q3 2023 | 2022-09-30 | -7.55 | 2023-11-07 | 10-Q |
| Q2 2023 | 2022-06-30 | -5.44 | 2023-08-08 | 10-Q |
| Q1 2023 | 2022-03-31 | -2.26 | 2023-05-09 | 10-Q |
| FY 2022 | 2021-12-31 | -11.15 | 2023-03-07 | 10-K |
| Q3 2022 | 2021-09-30 | -0.29 | 2022-11-08 | 10-Q |
| Q2 2020 | 2020-06-30 | -0.95 | 2020-08-06 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.